{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:26:36Z","timestamp":1783081596831,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s13277-014-2649-7","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T06:18:59Z","timestamp":1412662739000},"page":"757-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China"],"prefix":"10.1007","volume":"36","author":[{"given":"Yuqian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,8]]},"reference":[{"key":"2649_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2710.2010.01166.x","volume":"36","author":"B Champs-Bro des","year":"2011","unstructured":"des Champs-Bro B, Leroy-Cotteau A, Mazingue F, et al. Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. J Clin Pharm Ther. 2011;36:152\u201360.","journal-title":"J Clin Pharm Ther"},{"key":"2649_CR2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","volume":"96","author":"M Kurosawa","year":"2012","unstructured":"Kurosawa M, Yonezumi M, Hashino S, et al. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2012;96:748\u201357.","journal-title":"Int J Hematol"},{"key":"2649_CR3","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91:1068\u201375.","journal-title":"Haematologica"},{"key":"2649_CR4","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/jac\/dks266","volume":"67","author":"R Herbrecht","year":"2012","unstructured":"Herbrecht R, Caillot D, Cordonnier C, et al. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. J Antimicrob Chemother. 2012;67:2731\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2649_CR5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkp507","volume":"65","author":"C Hahn-Ast","year":"2010","unstructured":"Hahn-Ast C, Glasmacher A, M\u00fcckter S, et al. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J Antimicrob Chemother. 2010;65:761\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2649_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12360","author":"MC Arendrup","year":"2013","unstructured":"Arendrup MC, Boekhout T, Akova M, et al. ESCMID\/ECMM joint clinical guideline for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2013. doi: 10.1111\/1469-0691.12360 .","journal-title":"Clin Microbiol Infect"},{"key":"2649_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","volume":"93","author":"S Mousset","year":"2014","unstructured":"Mousset S, Buchheidt D, Heinz W, et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2014;93:13\u201332.","journal-title":"Ann Hematol"},{"issue":"Suppl 7","key":"2649_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","volume":"18","author":"AJ Ullmann","year":"2012","unstructured":"Ullmann AJ, Akova M, Herbrecht R, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect. 2012;18 Suppl 7:53\u201367.","journal-title":"Clin Microbiol Infect"},{"key":"2649_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jiph.2013.08.002","volume":"7","author":"AF Alothman","year":"2014","unstructured":"Alothman AF, Al-Musawi T, Al-Abdely HM, et al. Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: expert panel recommendations. J Infect Public Health. 2014;7:6\u201319.","journal-title":"J Infect Public Health"},{"key":"2649_CR10","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56\u201393.","journal-title":"Clin Infect Dis"},{"key":"2649_CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","volume":"31","author":"CR Flowers","year":"2013","unstructured":"Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:794\u2013810.","journal-title":"J Clin Oncol"},{"key":"2649_CR12","first-page":"507","volume":"32","author":"AX Song","year":"2011","unstructured":"Song AX, Huang Y, Yang DL, et al. Risk factors and prognosis of invasive fungal infections in patients with hematological diseases. Zhonghua Xue Ye Xue Za Zhi. 2011;32:507\u201311.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2649_CR13","first-page":"1026","volume":"48","author":"BH Huang","year":"2009","unstructured":"Huang BH, Li J, Liu JR, et al. The clinical features and risk factors for invasive fungal infection in multiple myeloma. Zhonghua Nei Ke Za Zhi. 2009;48:1026\u201330.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2649_CR14","first-page":"5","volume":"15","author":"CZ Zhang","year":"2009","unstructured":"Zhang CZ, Fung MA, Eisen DB. Disseminated fusariosis presenting as panniculitis-like lesions on the legs of a neutropenic girl with acute lymphoblastic leukemia. Dermatol Online J. 2009;15:5.","journal-title":"Dermatol Online J"},{"key":"2649_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3062.2010.00497.x","volume":"12","author":"P Zhang","year":"2010","unstructured":"Zhang P, Jiang EL, Yang DL, et al. Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience. Transpl Infect Dis. 2010;12:316\u201321.","journal-title":"Transpl Infect Dis"},{"key":"2649_CR16","first-page":"618","volume":"16","author":"ZY Wang","year":"2008","unstructured":"Wang ZY, Jiang EL, Zhang P, et al. Invasive fungal infections after allogeneic hematopoietic stem cell transplantation and related risk factors. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008;16:618\u201322.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2649_CR17","first-page":"486","volume":"46","author":"LP Xu","year":"2007","unstructured":"Xu LP, Ji Y, Liu DH, et al. The prevalence and risk factors of invasive fungal infection in hematopoietic stem cell transplant recipients. Zhonghua Nei Ke Za Zhi. 2007;46:486\u20139.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2649_CR18","first-page":"473","volume":"34","author":"Y Ji","year":"2013","unstructured":"Ji Y, Xu LP, Huang XJ. Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies. Zhonghua Xue Ye Xue Za Zhi. 2013;34:473\u20137.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2649_CR19","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"2649_CR20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MPH.0b013e31820acfc7","volume":"33","author":"N Watanabe","year":"2011","unstructured":"Watanabe N, Matsumoto K, Kojima S, et al. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole. J Pediatr Hematol Oncol. 2011;33:270\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2649_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1439-0507.2010.01881.x","volume":"54","author":"M Hoenigl","year":"2011","unstructured":"Hoenigl M, Zollner-Schwetz I, Sill H, et al. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Mycoses. 2011;54:454\u20139.","journal-title":"Mycoses"},{"key":"2649_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356:348\u201359.","journal-title":"N Engl J Med"},{"key":"2649_CR23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.11936","volume":"100","author":"GN Mattiuzzi","year":"2004","unstructured":"Mattiuzzi GN, Kantarjian H, Faderl S, et al. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004;100:581\u20139.","journal-title":"Cancer"},{"key":"2649_CR24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni A, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010;95:644\u201350.","journal-title":"Haematologica"},{"key":"2649_CR25","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jac\/dkt083","volume":"68","author":"F Guo","year":"2013","unstructured":"Guo F, Yang Y, Kang Y, et al. Invasive candidiasis in intensive care units in China: a multicentre prospective observational study. J Antimicrob Chemother. 2013;68:1660\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2649_CR26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","volume":"96","author":"MC Nicolle","year":"2011","unstructured":"Nicolle MC, B\u00e9net T, Thiebaut A, et al. Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica. 2011;96:1685\u201391.","journal-title":"Haematologica"},{"key":"2649_CR27","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1186\/cc10574","volume":"15","author":"H Muskett","year":"2011","unstructured":"Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care. 2011;15:R287. doi: 10.1186\/cc10574 .","journal-title":"Crit Care"},{"key":"2649_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2334-13-10","volume":"13","author":"SP Yang","year":"2013","unstructured":"Yang SP, Chen YY, Hsu HS, Wang FD, Chen LY, Fung CP. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis. 2013;13:10. doi: 10.1186\/1471-2334-13-10 .","journal-title":"BMC Infect Dis"},{"key":"2649_CR29","first-page":"175","volume":"3","author":"J Kriengkaukiyiat","year":"2011","unstructured":"Kriengkaukiyiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol. 2011;3:175\u201391.","journal-title":"Clin Epidemiol"},{"key":"2649_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","volume":"26","author":"L Ostrosky-Zeichner","year":"2007","unstructured":"Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007;26:271\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2649_CR31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1439-0507.2007.01366.x","volume":"50","author":"R Jorda-Marcos","year":"2007","unstructured":"Jorda-Marcos R, Alvarez-Lerma F, Jurado M, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses. 2007;50:302\u201310.","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"2649_CR32","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/jac\/dkq437","volume":"66","author":"L Pagano","year":"2011","unstructured":"Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66 Suppl 1:i5\u201314. doi: 10.1093\/jac\/dkq437 .","journal-title":"J Antimicrob Chemother"},{"key":"2649_CR33","unstructured":"Prevention and Treatment of Cancer-related Infections. National Comprehensive Cancer Network (NCCN) Guidelines. Available at: www.nccn.org ."},{"key":"2649_CR34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12032-009-9339-0","volume":"27","author":"J Wang","year":"2010","unstructured":"Wang J, Zhan P, Zhou R, et al. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials. Med Oncol. 2010;27:1082\u20138.","journal-title":"Med Oncol"},{"key":"2649_CR35","doi-asserted-by":"crossref","first-page":"738","DOI":"10.5414\/CP201880","volume":"51","author":"Y Shen","year":"2013","unstructured":"Shen Y, Huang XJ, Wang JX, et al. Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study. Int J Clin Pharmacol Ther. 2013;51:738\u201345.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2649_CR36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","volume":"48","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Pautas C, Maury S, et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis. 2009;48:1042\u201351.","journal-title":"Clin Infect Dis"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2649-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:57Z","timestamp":1559489397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2649-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,8]]}}}